Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 12, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/jpm12010006
Keywords
multiple sclerosis; relapse; pseudo-relapses; methylprednisolone; treatment algorithm
Ask authors/readers for more resources
Minimizing the risk of relapse is crucial in the treatment of multiple sclerosis (MS). This article aims to improve the quality of care for this neurological process by addressing key concepts, clinical examination recommendations, classification criteria, imaging techniques, biomarkers, and specific therapeutic advice for special populations. An algorithm for treating MS relapses is also provided.
Minimizing the risk of relapse is essential in multiple sclerosis (MS). As none of the treatments currently available are capable of completely preventing relapses, treatment of these episodes remains a cornerstone of MS care. The objective of this manuscript is to reduce uncertainty and improve quality of care of this neurological process. This article addresses definitions of key concepts, recommendations for clinical examination, classification criteria, magnetic resonance imaging, biomarkers, and specific therapeutic counsels including special populations such as pregnant and breastfeeding women, and children. An algorithm for treating MS relapses is also provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available